HARVARD BIOSCIENCE INC 4/A

Accession 0001181431-13-054956

$HBIOCIK 0001123494operating

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 4:12 PM ET

Size

24.4 KB

Accession

0001181431-13-054956

Form 4/AAmended

Period: 2013-10-18

Chief Operating Officer

Transactions

Tax Payment
Common Stock
2013-10-18$5.50/sh−36,265$199,458→ 456,499 total
Exercise/Conversion
Common Stock
2013-10-18$4.28/sh+38,025$162,747→ 528,564 total
Exercise/Conversion
Stock option (right to buy)
2013-10-18−47,247→ 152,753 total
Exercise: $3.18From: 2013-01-01Exp: 2019-05-21→ Common Stock, par value $0.01 per share (47,247 underlying)
Tax Payment
Common Stock
2013-10-18$5.50/sh−65,960$362,780→ 490,539 total
Exercise/Conversion
Common Stock
2013-10-18$1.99/sh+100,000$199,000→ 556,499 total
Tax Payment
Common Stock
2013-10-18$5.50/sh−33,377$183,574→ 495,187 total
Exercise/Conversion
Common Stock
2013-10-18$2.98/sh+12,500$37,250→ 507,687 total
Exercise/Conversion
Stock option (right to buy)
2013-10-18−100,000→ 0 total
Exercise: $1.99From: 2012-01-01Exp: 2018-12-04→ Common Stock, par value $0.01 per share (100,000 underlying)
Exercise/Conversion
Common Stock
2013-10-18$3.18/sh+47,247$150,245→ 492,764 total
Tax Payment
Common Stock
2013-10-18$5.50/sh−9,343$51,387→ 498,344 total
Exercise/Conversion
Stock option (right to buy)
2013-10-18−38,025→ 61,975 total
Exercise: $4.28From: 2010-01-01Exp: 2016-08-09→ Common Stock, par value $0.01 per share (38,025 underlying)
Exercise/Conversion
Stock option (right to buy)
2013-10-18−12,500→ 37,500 total
Exercise: $2.98From: 2009-01-01Exp: 2015-05-25→ Common Stock, par value $0.01 per share (12,500 underlying)

Footnotes (3)

[F1]Includes (a) a deferred stock award of 16,700 restricted stock units which will vest on Jan 1, 2014; (b) a deferred stock award of 9,374 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 30,954 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, and Jan 1, 2016; (d) and a deferred stock award of 19,337 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, Jan 1, 2016, and Jan 1, 2017; and (e) 369,152 shares of common stock held by Ms. Luscinski.
[F2]Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price and related withholding taxes. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934.
[F3]Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.

Documents

1 file

HARVARD BIOSCIENCE INC

CIK 0001123494

Entity typeoperating

IncorporatedDE